About CDC’s Progress


Surveillance & Science:

More effective tracking and prevention of healthcare-associated infections, foodborne illness, and gonorrhea

Improved Antibiotic Use:

Improving antibiotic use to ensure antibiotics are available and work to protect people from life-threatening infections or sepsis

Insights for Practice:

Innovations and collaborations with academic and healthcare partners to identify and implement new ways to prevent antibiotic-resistant infections and their spread in the U.S. and abroad.

Research and Development:

Sharing isolates that inform development of new drugs and diagnostics, and making public CDC’s sequencing data from AR pathogens to spur innovation in industry.

Download now: CDC is Innovating to Fight AR
Detection, Response & Containment

Laboratory & Diagnostics:

Gold-standard lab capacity offered to all U.S. state and regional labs through CDC’s AR Laboratory Network, and on-the-ground lab expertise and assistance in some countries abroad.

Epidemiology Capacity for Response:

Increased capacity in state and local health departments and some countries for rapid detection and faster response to outbreaks and emerging resistance related to healthcare-associated infections, foodborne bacteria, and gonorrhea—to contain and control spread.

Highlights since 2016

Whole genome sequencing on 16,000+ germ samples
AR Lab Network detects a resistant germ requiring investigations every 4 hours (as of 2018)
$550+ million distributed to 59 states and local health departments
Supporting 500+ local AR experts
Projects in the U.S. and 30+ Countries Abroad